Soluciones para la pérdida de peso diseñadas para transformar y mantener
Medicamentos para la longevidad diseñados para prolongar y mejorar
Wegovy® (Semaglutide) is an FDA-approved GLP-1 for chronic weight management, available as a once-daily pill or a once-weekly pen. If approved, Shed provides access through provider-led online care, fulfilled by a dispensing pharmacy and delivered to your door.
Wegovy® may help if appetite, cravings, or staying consistent keep getting in the way.
Across all Shed programs, members have seen what's possible with the right medication, personalized care, and ongoing support.












About 2 minutes • 100% online • No appointment required
Figures are based on self-reported data. Percentages of average weight loss are from VIP member data, while total pounds lost reflect self-reported data from all members. Results may vary. Some states may require virtual appointment.

*Free text-based coaching may include automated responses generated by an AI assistant. All communication is monitored and reviewed by a licensed coach for accuracy, safety, and quality of support. AI does not replace professional medical or mental health advice.

Wegovy® belongs to a class of medications called GLP-1 receptor agonists. It mimics a natural hormone that helps regulate appetite and blood sugar, supporting reduced food intake and healthier eating patterns with lifestyle changes.
Enter your current weight to see what different percentages of body-weight loss could mean in pounds.

Answer a few questions about your health history and goals.

A licensed medical provider reviews your answers and determines if Wegovy® is a good fit for you.

If prescribed, your medication is filled by a third-party dispensing pharmacy and delivered with clear instructions.

Unlimited provider follow-ups, Health Coaching, and support from your Member Success Team.




Your Shed program connects you with professionals who can support different parts of your weight-loss journey.
Shed connects eligible members with licensed medical providers and trusted pharmacy partners through a secure online treatment experience.



See the full Prescribing Information, including the Boxed Warning, and the Medication Guide.
†In clinical trials of Wegovy® (Semaglutide), adults who used Wegovy® alongside diet and lifestyle changes lost an average of 14% to 15% of their body weight over about one year. Individual results vary and are not guaranteed. *Shed member statistics reflect members across all Shed programs and are not specific to Wegovy®. 9.8% average weight loss is based on self-reported Shed member data, and total pounds lost reflects self-reported data from all members. Member photos show Shed members across all programs. Wegovy® pricing starts at $149/month (pill) and $199/month (pen) for new patients using cash pay. Prices do not include the $125/month Shed membership, which is paid directly to Shed. Medication costs are paid separately to the dispensing pharmacy. Wegovy® is an FDA-approved prescription medication for chronic weight management in adults with obesity, or overweight with at least one weight-related condition. Prescriptions are based on a medical evaluation and are at the provider's discretion. Shed is not a pharmacy and does not dispense medications. Prescriptions are fulfilled and shipped by a third-party dispensing pharmacy. Important Safety Information: Wegovy® may cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). Do not use Wegovy® if you or a family member has had MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Wegovy® may cause serious side effects, including pancreatitis, gallbladder problems, low blood sugar, kidney problems, serious allergic reactions, changes in vision in people with type 2 diabetes, increased heart rate, depression or thoughts of suicide, and stomach problems. The most common side effects include nausea, diarrhea, vomiting, constipation, stomach pain, headache, and fatigue. See the full Prescribing Information including the Boxed Warning, and the Medication Guide. Wegovy® is a registered trademark of Novo Nordisk A/S. Shed is not affiliated with or endorsed by Novo Nordisk.
*FSA/HSA eligibility depends on your individual plan. Please check with your plan administrator to confirm coverage before using your FSA/HSA card.
Compounded medications are not FDA-approved and are prepared by a licensed pharmacy based on a provider's prescription. A prescription is only issued after a consultation with a licensed provider who determines whether treatment is appropriate. Results may vary. Please refer to the Terms and Conditions for full details on the Shed weight-loss guarantee. In clinical trials of Wegovy® (2.4 mg), average weight loss was 15% and 20% when paired with diet and exercise.